Changes in Lymphocyte Subpopulations after Remdesivir Therapy for COVID-19: A Brief Report
Description
Remdesivir (RDV) has demonstrated clinical benefit in hospitalized COronaVIrus Disease (COVID)-19 patients. The objective of this brief report was to assess a possible correlation between RDV therapy and the variation in lymphocyte subpopulations. We
